AGN-151586 Dose-Ranging Study for Treatment of Glabellar Lines
Condition: Glabellar Lines Interventions: Drug: AGN-151586; Drug: Placebo Sponsor: Allergan Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials